Risk Factors of Venous Thrombotic Event in Interstitial Lung Disease

NCT07833254 — Not yet recruiting, 100 participants, Sohag University

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

Incidence , Risk Factors and Clinical Outcomes of Venous Thrombotic Events in Hospitalized Patients With Interstitial Lung Disease

Registry	NCT07833254
Status	Not yet recruiting
Study type	Observational
Enrollment	100 (Estimated)
Sponsor	Sohag University (Other)
Conditions	Interstitial Lung Disease, Venous Thromboembolism, Pulmonary Embolism, Deep Venous Thrombosis
Dates	start 2026-09-01 (estimated), primary completion 2027-08-31 (estimated), completion 2027-08-31 (estimated), first posted 2026-09-22, last updated 2026-09-22

-Summary

This study aims to determine the incidence of venous thromboembolic events (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), among hospitalized patients with interstitial lung disease (ILD). It will also identify potential risk factors associated with VTE and evaluate its impact on clinical outcomes. Patients with ILD admitted to the hospital will be assessed for clinical characteristics, disease severity, risk factors for thrombosis, and the occurrence of DVT or PE during hospitalization. The study findings may help improve early recognition of VTE and guide appropriate preventive and diagnostic strategies in hospitalized patients with ILD.

Expand all sections · Collapse all

+Arms and interventions

Arm	Type	Interventions	Description
One group

+Outcome measures

Primary outcomes

Primary outcome: Incidence of venous thromboembolic events (VTE) [One Year]: Number and proportion of adult patients with ILD who develop objectively confirmed venous thromboembolic events, defined as DVT and/or pulmonary embolism, during hospitalization.

Secondary outcomes

Length of hospital stay [One year]
Requirement and level of respiratory support [One Year]
ICU admission and length of ICU stay [One Year]
In-hospital mortality [One Year]

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Age ≥ 18 years. Patients admitted to the respiratory ICU, Chest Department

Exclusion Criteria:

* Age < 18 years. Patients already receiving therapeutic anticoagulation before admission. Known inherited thrombophilia. Active malignancy. Pregnancy. Patients refusing participation. Recent major surgery or trauma within previous 4 weeks.